Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05561894
Other study ID # master 1
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 15, 2022
Est. completion date October 20, 2023

Study information

Verified date November 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Neurosurgical operations are characterised by major fluid shift, frequent use of diuretics, and prolonged operative time. The role of fluid therapy in these patients is very critical; hypovolemia might decrease cerebral perfusion; while, fluid over-infusion might swell the brain (1-3). Thus, fluid management in these procedures complex and challenging. Evidence on the optimum protocol for intraoperative fluid management in neurosurgical patients is still lacking. Adequate intracranial volume management is considered a key factor that would overcome the tumour bulk and the surrounding vasogenic oedema facilitating surgical access . Thus, a relaxed brain is one of the targets of intraoperative fluid management during craniotomy. The slack brain would allow proper surgical retraction and consequently, reduces brain retractor ischemia. Brain relaxation scale (BRS) had shown a good correlation with intracranial pressure thus, an increasing interest was paid to BRS as a simple surrogate for intracranial pressure (4-8). Goal-directed hemodynamic therapy (GDT) in the operating room is a term used to describe the use of defined hemodynamic targets to guide intravenous fluid and inotropic therapy. Pulse pressure variation (PPV) is one of the robust dynamic indices of fluid responsiveness which is based on heart-lung interactions (9-12). GDT had been frequently investigated in the operating room in high-risk patients especially in major surgery. However, the impact of GDT on patient outcomes, especially BRS, is not well evaluated in brain surgery (12-15). In this study, we evaluated PPV-guided fluid management compared to standard fluid management in patients undergoing supratentorial mass excision. We hypothesised that in these procedures, GDT might restrict intraoperative fluid volume, improve brain relaxation, and provide stable patient hemodynamics.


Description:

Anesthetic management: Peripheral i.v line will be inserted and 2-3 mg midazolam and 2 gm magnesium are given. A pre-induction radial arterial line is inserted with the aid of infiltration of 2 ml lidocaine 2%. Invasive arterial blood pressure monitoring is started and pulse oximetry, 5-leads ECG, and NIBP are attached to the patient and mindray ipm-12 monitor is used. Anesthetic induction started with propofol 1-2 mg/kg, lidocaine 1 mg/kg, cis-atracurium 0.2 mg/kg and fentanyl 1-2 microgram/kg. Intubation is done with cuffed endotracheal tube and tidal volume and respiratory rate are set to achieve end-tidal Co2 of 30-28 mmHg. Esophageal temperature probe and urinary catheter are put in place. Patients then will receive maintenance of anesthesia with isoflurane < 1 MAC, propofol 10-60 microgram/kg/min, dexmedetomidine loading 1 microgram/kg bolus in 10 minutes followed by 0.2-1 microgram/kg/hour and cis-atracurium 2-3 microgram/kg/minute. Patients will receive mannitol 20% 0.5-1 gm/kg and dexamethasone 8mg and paracetamol 1gm near the end of surgery. Patients will receive their fasting requirements of normal saline in the first 3 hours of surgery. Maintenance fluid used will be ringer acetate and will be given according to pulse pressure variation index (PPVI) that is derived from pulse contour analysis of invasive arterial blood pressure waveform. Patients are then divided into two groups of two different targets of PPVI. Group A will be given ringer acetate when PPVI is > 12% and group B will be given ringer acetate when PPVI is > 16%. If hypotension occurred without change in PPVI targets, it will be treated with 10 mg ephedrine. Arterial blood gas samples will be collected at induction and at the end of surgery. After removal of cranial fixation pins, anesthesia is discontinued and reversal of muscle relaxant is done with atropine 0.5 mg and neostigmine 0.05 mg/kg then extubation is done and patient is transferred to the ICU.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date October 20, 2023
Est. primary completion date September 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: ASA 1,2 patients undergoing supratentorial tumour resection Age > 18 years Supine position Exclusion Criteria: - ASA 3,4 patients and patients with GCS < 13 - Any other position rather than supine position - AF or any significant arrhythmia - Severe bradycardia that leads to low HR/RR ratio - Severe tricuspid regurgitation or severe right ventricular dysfunction - Patients with severe restrictive lung pathology and needing low tidal volumes

Study Design


Related Conditions & MeSH terms


Intervention

Other:
pulse pressure variation index guided fluid therapy
maintainence intraoperative fluid therapy (ringer's acetate) will be given guided by either two goals of pulse pressure variation index, either >12% or >16%

Locations

Country Name City State
Egypt Faculty of medicine, Assiut university Assiut Asyut Governorate

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary intraoperative mean arterial blood pressure measured by invasive arterial blood pressure through radial arterial line before induction of anesthesia as a baseline, after induction and then every 15 minutes till the end of surgery
Secondary postoperative adverse cardiovascular outcomes incidence of hypotension < 25% of baseline blood pressure 24 hours postoperative
Secondary intraoperative urine output total amount of urine output at the end of surgery at the end of surgery
See also
  Status Clinical Trial Phase
Completed NCT01060631 - Influence of Intracranial Lesions on Bispectral Index N/A
Recruiting NCT05874050 - Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
Recruiting NCT05763836 - Comparison of the Analgesic Effects of Scalp Nerve Block and Intravenous Ibuprofen Applications Under the Guidance of Nociception Level Index (NoL) in Patients Undergoing Elective Supratentorial Craniotomy Phase 4
Not yet recruiting NCT05930288 - The Effect of Preoperative Walking Exercises on the Prognosis of Supratentorial Brain Tumours Patients After Craniotomy N/A
Not yet recruiting NCT06406829 - Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy N/A
Completed NCT03318471 - Magnesium Sulphate for Attenuation of Hemodynamic Pressor Response After Myfield's Clamp Application Phase 4
Not yet recruiting NCT04141319 - Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Post-craniotomy Pain Phase 4
Completed NCT03570203 - Spectrum of Serum Sodium Disturbances in Patients With Non-sellar/Suprasellar Supratentorial Tumors
Not yet recruiting NCT04380298 - Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain Phase 4
Not yet recruiting NCT03454659 - Comparison of the Effect of Low and High Fraction of Inspired Oxygen on Postoperative Surgical Field Infection N/A
Completed NCT01864499 - Perioperative Evaluation of Intracranial Hypertension by Ultrasound Measurement of Variations in the Diameter of the Sheath of the Optic Nerve in the Excision of a Tumor or Biopsy Supratentorial Brain N/A